The Week

Nutrien fell 6.3% this week to close at $72.23, while the S&P 500 gained 1.21%, leaving the stock to underperform by about 7.51 percentage points. The week opened higher and faded: Monday (Sep 21) started at $76.59 and hit a high of $77.03 before selling off, with Friday (Sep 25) touching a low of $70.74 and closing just above that. Weekly amplitude came to 8.21%. Average daily volume was 3.23m shares, about 29% above the 60-day median, pointing to heavier-than-usual turnover.

Key Events

Company-specific news was limited but concentrated. On Monday (Sep 21), the transcript of Nutrien’s Q2 2026 earnings conference call was released, giving investors a chance to revisit management’s latest remarks on fertiliser demand and pricing. The next day brought a geopolitical headline tied to Canada, with Trump engaging a close Putin ally; Nutrien, as a major Canadian fertiliser producer, sits in the background of that discussion. On Wednesday (Sep 23), the company announced it will host an Investor Day on November 30, setting a date for updated operational guidance. Taken together, the week’s news flow was relatively mild, with no direct company-specific negative disclosure.

Analyst Ratings

Based on the latest data, 25 institutions cover Nutrien: 8 rate it buy, 7 overweight, 8 hold, and 2 sell. That works out to 15 buy or overweight ratings and 10 hold or sell ratings. The consensus recommendation is buy, with a consensus target of $76.90, roughly 6.47% above the last close of $72.23. The target range is wide, from a low of $59 to a high of $90, suggesting meaningful disagreement about the earnings outlook. Within the fertiliser and agrochemical industry, Nutrien ranks first among 11 peers.

The Week Ahead

Next week brings a busy macro calendar. On Monday (Sep 28), the US Dallas Fed manufacturing business activity index is due, with a prior reading of 11.6. Tuesday (Sep 29) is heavier: FHFA house prices, the Case Shiller 20-city index, JOLTS job openings, and consumer confidence. JOLTS has a prior of 7.271m against a forecast of 7.24m, while consumer confidence is expected at 90 versus 89.4 previously. On the company side, Nutrien’s fiscal Q3 2026 results are scheduled for after the close on November 5, with consensus estimates around $0.98 EPS and $5.673bn in revenue. Investor Day follows on November 30.

In Short

Nutrien’s pullback this week diverged sharply from a rising S&P 500, and the higher volume suggests selling pressure was concentrated. On the flows side, the latest session shows large-lot money as a net seller, while mid and small orders pointed in different directions. Valuation sits at about 14.48x P/E and 1.33x P/B, in the lower-middle part of its range. Brokers are mostly constructive, but the wide target band and a consensus target only modestly above spot leave room for debate. The next catalysts are the Q3 earnings print and the Investor Day guidance, which will show whether the current estimates hold up and whether the gap between bull and bear targets narrows.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.